{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-031475","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2024-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.239399+00:00","generated_at":"2026-06-05T02:44:40.606105+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"NRx Pharmaceuticals underwriters exercise overallotment, issue 750K shares at $0.30","bullets":["Underwriters exercised overallotment option for 750,000 shares at $0.30/share, closed March 6, 2024.","Option shares are part of the underwritten public offering announced Feb 27, 2024, with EF Hutton as lead underwriter.","Gross proceeds from the option exercise total approximately $225,000 before underwriting discounts."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-031475","json":"https://secwatch.observer/filing/0001104659-24-031475.json","markdown":"https://secwatch.observer/filing/0001104659-24-031475.md","text":"https://secwatch.observer/filing/0001104659-24-031475.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000110465924031475/0001104659-24-031475-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000110465924031475/tm248115d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T02:44:40.606105+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}